Korean J Obstet Gynecol.  2002 Jul;45(7):1236-1240.

A case of carcinosarcoma of uterine endometrium associated with Tamoxifen use in breast cancer patient

Affiliations
  • 1Department of Obstetrics & Gynecology, College of Medicine, Soonchunhyung University, Seoul, Korea.
  • 2Department of Anatomic Pathology, College of Medicine, Soonchunhyung University, Seoul, Korea.

Abstract

Tamoxifen, which is often used in breast cancer therapy, has also been used in the treatment of patients with advanced and recurrent endometrial carcinoma. Tamoxifen has been shown to have significant benificial effects in the treatment of breast cancer patients as hormonal therapy. However, there is evidence that tamoxifen may affect other hormone sensitive organs, including the uterus and ovaries. An increased risk of endometrial polyps, endometrial hyperplasia and endometrial cancer has been reported in tamoxifen treated women. We are able to make this report because we have experienced uterine endometrial carcinosarcoma which is developed in a patient treated with tamoxifen for five years following a modified radical mastectomy due to breast cancer in our hospital.

Keyword

Tamoxifen; Carcinosarcoma

MeSH Terms

Breast Neoplasms*
Breast*
Carcinosarcoma*
Endometrial Hyperplasia
Endometrial Neoplasms
Endometrium*
Female
Humans
Mastectomy, Modified Radical
Ovary
Polyps
Tamoxifen*
Uterus
Tamoxifen
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr